Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-73,239
Closed -$3.7M 86
2019
Q3
$3.7M Buy
73,239
+704
+1% +$34.6K 0.31% 60
2019
Q2
$3.49M Sell
72,535
-4,522
-6% -$209K 0.27% 63
2019
Q1
$3.73M Sell
77,057
-9,718
-11% -$438K 0.26% 61
2018
Q4
$3.65M Sell
86,775
-18,527
-18% -$760K 0.27% 54
2018
Q3
$4.32M Buy
105,302
+1,589
+2% +$64.2K 0.33% 53
2018
Q2
$4.12M Buy
103,713
+61,882
+148% +$2.38M 0.32% 55
2018
Q1
$1.56M Buy
+41,831
New +$1.69M 0.14% 64

Other funds holding HOLX

Majedie Asset Management's HOLX Position: Q4 2019 in Review

Majedie Asset Management sold out of Hologic (HOLX) in Q4 2019, closing a stake of 73,239 shares — an estimated $3.7M sold.

Majedie Asset Management first reported a position in HOLX in Q1 2018 and held it in 7 quarters. The position peaked at $4.32M in Q3 2018. 520 funds tracked by Wall St. Rank hold HOLX as of Q4 2019.

  • Majedie Asset Management reported no remaining Hologic position as of Q4 2019 after selling out during the quarter.
  • Majedie Asset Management sold 73,239 Hologic shares in Q4 2019, an estimated $3.7M.
  • Majedie Asset Management first reported a position in Hologic in Q1 2018 and held it in 7 quarters.
  • Majedie Asset Management's Hologic position peaked at $4.32M in Q3 2018.
  • 520 funds tracked by Wall St. Rank held Hologic as of Q4 2019.

Based on Majedie Asset Management's 13F filing for Q4 2019, filed 7 Feb 2020.